Announcement on Obtaining Drug Registration Certificate
Filed with SSE · · 2 pages · Chinese
Shandong Lukang Pharmaceutical Co., Ltd. on 6ix
Earlier from Shandong Lukang Pharmaceutical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Annual Report on Continuous Supervision for 2025 of Shandong Lukang Pharmaceutical Co., Ltd. by China International Capital Corporation Limited
- Announcement on Resolutions of the 13th Meeting of the 11th Board of Directors
- Announcement on Progress in Bid for the Equity of Shandong Luhang Hecheng Pharmaceutical Co., Ltd.
- Announcement on Completion of Inclusion of the First Subject in Phase IIb Clinical Trial of CMS203 Tablets
Later from Shandong Lukang Pharmaceutical
- Announcement on Obtaining Approval for Marketing of Chemical API Aprepitant
- Announcement on Circulation of Restricted Shares Issued to Specific Objects
- Announcement on Acquisition of Drug Registration Certificate by a Holding Subsidiary
- Announcement on Change of Name and Business Scope of Wholly-owned Subsidiary
- Announcement on Implementation of Dividend Distribution for 2025
Follow Shandong Lukang Pharmaceutical into a list and get an email when it puts out news.
Follow Shandong Lukang Pharmaceutical